Chennai-based clinical research organization Quest Life Sciences Pvt Ltd has made a strategic acquisition by acquiring the assets of Fortis Clinical Research Ltd (FCRL), a division of Fortis Hospitals Group. Fortis Clinical Research provides clinical research services to the pharmaceutical, biotechnology and device companies across the globe. FCRL has an established Bioavailability/Bioequivalence (BA/BE) studies centre in Faridabad and primarily served Ranbaxy for its submissions and approvals. Quest Life Sciences offers a full array of clinical trial services, having extensive experience in conducting PK/PD studies. The company offers complete range of ICH GCP compliant services for phase I to IV clinical trials and delivers cost effective, timely research solutions to the pharmaceutical industries worldwide.